In major reversal, Kennedy tells senators he won't take money from vaccine lawsuit
Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...
Kennedy Says He Will Give HPV Vaccine Lawsuit Proceeds to His Son
Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...
Kennedy to divest interest from HPV vaccine lawsuits
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
IJR19h
Senate Committees Waging War On RFK Jr.’s MAHA Vision Are Knee Deep In Big Pharma, Food Industry Cash
Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...
Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?
We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...
Merck & Co. Inc. stock underperforms Monday when compared to competitors despite daily gains
Merck & Co. Inc. closed 27.25% short of its 52-week high of $134.63, which the company reached on June 25th.
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...
What to know about RFK Jr.'s financial ties with a personal industry law firm
Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.
RFK Jr pledges to divest from vaccine lawsuit after conflict of interest concerns
One of the concerns levied by Sen. Elizabeth Warren (D-MA) stemmed from Kennedy's financial ties to a lawsuit against Merck ...
Merck & Company Hold Rating: Promising Drug Developments Amid Uncertain Financial Outlook
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
Merck's SWOT analysis: pharma giant's stock faces China setback, PAH potential
Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial ...